{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:54:03Z","timestamp":1772733243796,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.anpede.2025.503802","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T16:48:35Z","timestamp":1749660515000},"page":"503802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in three adolescents with heart failure due to non-obstructive hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"102","author":[{"given":"Carlos","family":"Baena-Palomino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Castellano-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mois\u00e9s","family":"Rodr\u00edguez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"37","key":"10.1016\/j.anpede.2025.503802_bib0005","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J."},{"issue":"37","key":"10.1016\/j.anpede.2025.503802_bib0010","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J."},{"issue":"3","key":"10.1016\/j.anpede.2025.503802_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100843","article-title":"Impact of sodium-glucose cotransporter 2 inhibitors on mortality in hypertrophic cardiomyopathy","volume":"3","author":"Aglan","year":"2024","journal-title":"JACC Adv."},{"issue":"1","key":"10.1016\/j.anpede.2025.503802_bib0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00246-022-02983-0","article-title":"Early clinical experience with dapagliflozin in children with heart failure","volume":"44","author":"Newland","year":"2023","journal-title":"Pediatr Cardiol."},{"key":"10.1016\/j.anpede.2025.503802_bib0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00246-023-03332-5","article-title":"Experience with SGLT2 inhibitors in patients with single ventricle congenital heart disease and fontan circulatory failure","volume":"46","author":"Konduri","year":"2025","journal-title":"Pediatr Cardiol."},{"issue":"4","key":"10.1016\/j.anpede.2025.503802_bib0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.6065\/apem.2244166.083","article-title":"Clinical studies of dapagliflozin in pediatric patients: a rapid review","volume":"27","author":"Grube","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab."}],"container-title":["Anales de Pediatr\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287925001632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287925001632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:53:04Z","timestamp":1772729584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341287925001632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2341287925001632"],"URL":"https:\/\/doi.org\/10.1016\/j.anpede.2025.503802","relation":{},"ISSN":["2341-2879"],"issn-type":[{"value":"2341-2879","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in three adolescents with heart failure due to non-obstructive hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpede.2025.503802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2025.503802","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"503802"}}